A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development

被引:9
|
作者
Bai, Jane P. F. [1 ]
Earp, Justin C. [1 ]
Strauss, David G. [1 ]
Zhu, Hao [1 ]
机构
[1] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
来源
关键词
D O I
10.1002/psp4.12567
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:675 / 677
页数:3
相关论文
共 50 条
  • [31] Transporters in Drug Development and Clinical Pharmacology
    Giacomini, K. M.
    Huang, S-M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (01) : 3 - 9
  • [32] The Journal of Clinical Pharmacology, Clinical Pharmacology in Drug Development, and the Impact Factor
    Bertino, Joseph S., Jr.
    Greenblatt, David J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (05): : 545 - 546
  • [33] The Journal of Clinical Pharmacology, Clinical Pharmacology in Drug Development, and the Impact Factor
    Bertino, Joseph S., Jr.
    Greenblatt, David J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (03): : 218 - 219
  • [34] A framework for simplification of quantitative systems pharmacology models in clinical pharmacology
    Derbalah, Abdallah
    Al-Sallami, Hesham
    Hasegawa, Chihiro
    Gulati, Abhishek
    Duffull, Stephen B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (04) : 1430 - 1440
  • [35] A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability
    Anna Sher
    Steven A. Niederer
    Gary R. Mirams
    Anna Kirpichnikova
    Richard Allen
    Pras Pathmanathan
    David J. Gavaghan
    Piet H. van der Graaf
    Denis Noble
    Bulletin of Mathematical Biology, 2022, 84
  • [36] A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability
    Sher, Anna
    Niederer, Steven A.
    Mirams, Gary R.
    Kirpichnikova, Anna
    Allen, Richard
    Pathmanathan, Pras
    Gavaghan, David J.
    van der Graaf, Piet H.
    Noble, Denis
    BULLETIN OF MATHEMATICAL BIOLOGY, 2022, 84 (03)
  • [37] Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development
    Gibbs, John P.
    Menon, Rajeev
    Kasichayanula, Sreeneeranj
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 196 - 198
  • [38] Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review
    Samant, Tanay S.
    Mangal, Naveen
    Lukacova, Viera
    Schmidt, Stephan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (11): : 1207 - 1217
  • [39] Quantitative systems pharmacology approaches to increase confidence in rationale for drug discovery and development programs
    Musante, Cynthia J.
    Allen, Richard
    Rieger, Theodore R.
    Thompson, W. Clayton
    DRUG METABOLISM REVIEWS, 2016, 48 : 11 - 11
  • [40] Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices
    Bai, Jane P. F.
    Earp, Justin C.
    Pillai, Venkateswaran C.
    AAPS JOURNAL, 2019, 21 (04):